Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives.

Shulman LP.

Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S9-13. doi: 10.1016/j.ajog.2011.06.057. Review.

PMID:
21961825
2.

Metabolic effects of contraceptive steroids.

Sitruk-Ware R, Nath A.

Rev Endocr Metab Disord. 2011 Jun;12(2):63-75. doi: 10.1007/s11154-011-9182-4. Review.

PMID:
21538049
3.

The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives.

Burke AE.

Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S14-7. doi: 10.1016/j.ajog.2011.04.033. Epub 2011 Apr 29. Review.

PMID:
21961819
4.

Progestins for contraception: modern delivery systems and novel formulations.

Royer PA, Jones KP.

Clin Obstet Gynecol. 2014 Dec;57(4):644-58. doi: 10.1097/GRF.0000000000000072. Review.

PMID:
25314087
5.

Hormonal contraception: noncontraceptive benefits and medical contraindications.

Rager KM, Omar HA.

Adolesc Med Clin. 2005 Oct;16(3):539-51.

PMID:
16183538
6.

[Current aspects of the oral hormonal contraception].

Avramova V.

Akush Ginekol (Sofiia). 2008;47 Suppl 2:49-59. Bulgarian. No abstract available.

PMID:
19504710
7.

Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes.

Bergendal A, Persson I, Odeberg J, Sundström A, Holmström M, Schulman S, Björgell O, Kieler H.

Obstet Gynecol. 2014 Sep;124(3):600-9. doi: 10.1097/AOG.0000000000000411. Erratum in: Obstet Gynecol. 2015 Feb;125(2):495.

PMID:
25162263
8.

[Diffuse symptoms in young women may indicate venous thromboembolism. Important to ask about the use of combined hormonal contraception].

Milsom I, von Sydow H, Thörn AB, Björkelund C, Odlind V.

Lakartidningen. 2012 Sep 19-26;109(38):1680-2. Swedish. No abstract available.

PMID:
23094400
9.

Venous thromboembolism in women taking hormonal contraceptives.

Blanco-Molina A, Monreal M.

Expert Rev Cardiovasc Ther. 2010 Feb;8(2):211-5. doi: 10.1586/erc.09.175. Review.

PMID:
20136607
10.

Progestin-only contraception and venous thromboembolism.

Blanco-Molina MA, Lozano M, Cano A, Cristobal I, Pallardo LP, Lete I.

Thromb Res. 2012 May;129(5):e257-62. doi: 10.1016/j.thromres.2012.02.042. Epub 2012 Mar 16. Review.

PMID:
22425318
11.

Recent advances in hormonal contraception.

Erkkola R.

Curr Opin Obstet Gynecol. 2007 Dec;19(6):547-53. Review.

PMID:
18007132
12.

The adverse effects of hormonal therapy.

Bush TL.

Cardiol Clin. 1986 Feb;4(1):145-52. Review.

PMID:
3518931
13.

Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.

Maxwell GL, Schildkraut JM, Calingaert B, Risinger JI, Dainty L, Marchbanks PA, Berchuck A, Barrett JC, Rodriguez GC.

Gynecol Oncol. 2006 Nov;103(2):535-40. Epub 2006 Jun 5.

PMID:
16740300
14.

Sex steroids and breast cancer prevention.

Spicer DV, Pike MC.

J Natl Cancer Inst Monogr. 1994;(16):139-47. Review.

PMID:
7999456
15.

The state of hormonal contraception today: established and emerging noncontraceptive health benefits.

Maguire K, Westhoff C.

Am J Obstet Gynecol. 2011 Oct;205(4 Suppl):S4-8. doi: 10.1016/j.ajog.2011.06.056. Review.

PMID:
21961824
16.

Ovarian and endometrial function during hormonal contraception.

ESHRE Capri Workshop Group..

Hum Reprod. 2001 Jul;16(7):1527-35. Review.

PMID:
11425842
17.
18.

[Venous thromboembolism and oral contraception].

Veljković M, Popovć J.

Med Pregl. 2010 May-Jun;63(5-6):376-9. Review. Serbian.

PMID:
21186550
19.

[Peroral hormonal contraception and risk of venous thromboembolism].

Ludka O, Spinar J, Musil V, Pozdísek Z.

Vnitr Lek. 2010 May;56(5):370-5. Czech.

PMID:
20578585
20.

[Hormonal contraception using estroprogestins].

Grio R, Piacentino R, Cellura A, Caccuri D, Zaccheo F, Baccarini G, Marchino GL, Borgarino S, Fuda G.

Minerva Ginecol. 1990 Mar;42(3):49-53. Review. Italian.

PMID:
2187166

Supplemental Content

Support Center